Overview

Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study

Status:
Recruiting

Trial end date:
2023-07-11

Target enrollment:

Participant gender:

Summary

The Safety, Tolerability, Pharmacokinetics and antiviral activity Study of Anti hepatitis B virus treatment drug Freethiadine in Healthy subjects and in patients with chronic hepatitis B

Phase:

Phase 1

Details

Lead Sponsor:

Sunshine Lake Pharma Co., Ltd.

Treatments:

Entecavir